Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia

被引:26
|
作者
Bhutani, Vinod K. [1 ]
Srinivas, Shanmukha [1 ]
Cuadrado, Martin E. Castillo [1 ]
Aby, Janelle L. [2 ]
Wong, Ronald J. [1 ]
Stevenson, David K. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA
[2] Stanford Univ, Div Gen Pediat, Sch Med, Stanford, CA 94305 USA
关键词
Bilirubin; Bilirubin elimination; Bilirubin production; End-tidal carbon monoxide; Newborn jaundice; TIDAL CARBON-MONOXIDE; BILIRUBIN PRODUCTION; PULMONARY EXCRETION; NEAR-TERM; INFANTS; RISK; PREDICTION; JAUNDICE; INDEX;
D O I
10.1111/apa.13341
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
AimRelative contributions of increased production [by end-tidal carbon monoxide concentrations (ETCOc)] and decreased elimination of bilirubin to predischarge hour-specific total bilirubin (TB) levels were assessed in healthy late-preterm and term newborns. Secondly, we report predischarge ETCOc ranges to guide clinical management of hyperbilirubinemia. MethodsTB and ETCOc (3 timepoints) determinations of newborns aged between six hours and <6 days (n = 79) were stratified by postnatal age epochs. Hyperbilirubinemia risk was assessed by plotting TB values as a function of ETCOc. ResultsStratifications of ETCOc (in ppm, mean, median and interquartile ranges) by postnatal age epochs (0-24, 24-48 and 48-72) were as follows: 2.0, 1.9, 1.8-2.2 (n = 11); 1.6, 1.5, 1.1-2.0 (n = 58); and 2.0, 1.8, 1.6-2.3 (n = 9), respectively. Infants with ETCOc 2.5 were at high risk, between 1.5 and 2.5 at moderate risk and 1.5 were at low risk. Risk due to haemolysis alone was not independent (p < 0.01). For infants with TB >75th percentile (n = 31), 23% had ETCO 1.5, and 77% had ETCOc > 1.5 (p < 0.00003). ConclusionNear-simultaneous ETCOc and TB measurements in infants with TB >75th percentile accurately identify haemolytic hyperbilirubinemia.
引用
收藏
页码:E189 / E194
页数:6
相关论文
共 50 条
  • [21] Neonatal hyperbilirubinemia
    Schwoebel, A
    Gennaro, S
    [J]. JOURNAL OF PERINATAL & NEONATAL NURSING, 2006, 20 (01) : 103 - 107
  • [22] NEONATAL HYPERBILIRUBINEMIA
    BROWDY, S
    [J]. CLINICAL PEDIATRICS, 1966, 5 (02) : 126 - &
  • [23] Neonatal Hyperbilirubinemia
    Lee, Brian
    Piersante, Tracy
    Calkins, Kara L.
    [J]. PEDIATRIC ANNALS, 2022, 51 (06): : E219 - E227
  • [24] NOVOBIOCIN AND NEONATAL HYPERBILIRUBINEMIA - AN INVESTIGATION OF RELATIONSHIP IN AN EPIDEMICOF NEONATAL HYPERBILIRUBINEMIA
    SUTHERLAND, J
    KELLER, WH
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1961, 101 (04): : 447 - +
  • [25] Thoughts on current management of severe neonatal hyperbilirubinemia
    Di Maio, M
    Besnier, S
    [J]. ARCHIVES DE PEDIATRIE, 2002, 9 (10): : 1083 - 1086
  • [26] MANAGEMENT OF NEONATAL HYPERBILIRUBINEMIA - RATIONAL USE OF PHOTOTHERAPY
    POLIN, RA
    [J]. BIOLOGY OF THE NEONATE, 1990, 58 : 32 - 43
  • [27] Neonatal hyperbilirubinemia: An evidence-based approach
    Pace, Emma J.
    Brown, Carina M.
    DeGeorge, Katharine C.
    [J]. JOURNAL OF FAMILY PRACTICE, 2019, 68 (01): : E4 - E11
  • [28] EFFICACY OF PHOTOTHERAPY IN PREVENTION AND MANAGEMENT OF NEONATAL HYPERBILIRUBINEMIA
    BROWN, AK
    KIM, MH
    WU, PYK
    BRYLA, DA
    [J]. PEDIATRICS, 1985, 75 (02) : 393 - 400
  • [29] NEONATAL HYPERBILIRUBINEMIA AND OXYTOCIN
    BEAZLEY, JM
    ALDERMAN, B
    [J]. LANCET, 1975, 1 (7897): : 45 - 45
  • [30] PHOTOTHERAPY FOR NEONATAL HYPERBILIRUBINEMIA
    PRATESI, R
    AGATI, G
    FUSI, F
    [J]. PHOTODERMATOLOGY, 1989, 6 (06) : 244 - 257